| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.78▼ | 1.78▼ | 1.80▼ | 1.78▼ | 1.37▲ |
| MA10 | 1.79▼ | 1.81▼ | 1.78▼ | 1.86▼ | 1.03▲ |
| MA20 | 1.80▼ | 1.79▼ | 1.77▼ | 1.43▲ | 0.91▲ |
| MA50 | 1.82▼ | 1.79▼ | 1.87▼ | 0.98▲ | 1.14▲ |
| MA100 | 1.80▼ | 1.88▼ | 1.72▲ | 0.89▲ | 3.35▼ |
| MA200 | 1.78▼ | 1.66▲ | 1.19▲ | 0.96▲ | 10.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.005▼ | 0.004▲ | 0.002▲ | 0.172▲ |
| RSI | 31.058▼ | 42.607▼ | 44.548▼ | 63.331▲ | 64.338▲ |
| STOCH | 31.111 | 30.417 | 62.386 | 42.939 | 44.700 |
| WILL %R | -100.000▼ | -70.000 | -72.727 | -37.139 | -30.857 |
| CCI | -279.072▼ | -111.304▼ | -61.057 | 12.372 | 148.560▲ |
|
Thursday, October 16, 2025 02:00 PM
Palisade Bio ( ($PALI) ) has shared an announcement. On October 15, 2025, Palisade Bio, Inc. announced it had $133.3 million in cash and cash ...
|
|
Monday, October 13, 2025 05:54 AM
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ...
|
|
Thursday, October 09, 2025 02:00 PM
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 1.71 | 1.88 | 1.70 | 1.74 | 5,079,600 |
| 16/10/25 | 1.75 | 1.90 | 1.67 | 1.73 | 5,547,300 |
| 15/10/25 | 1.80 | 1.85 | 1.6582 | 1.73 | 5,683,530 |
| 14/10/25 | 1.83 | 1.92 | 1.75 | 1.85 | 2,669,700 |
| 13/10/25 | 2.03 | 2.03 | 1.70 | 1.85 | 7,899,274 |
| 10/10/25 | 2.07 | 2.14 | 1.83 | 2.00 | 9,154,800 |
| 09/10/25 | 1.94 | 2.28 | 1.94 | 2.10 | 11,645,663 |
| 08/10/25 | 1.85 | 2.16 | 1.7144 | 2.00 | 20,275,635 |
| 07/10/25 | 1.98 | 2.00 | 1.64 | 1.68 | 13,923,300 |
| 06/10/25 | 1.96 | 2.28 | 1.72 | 1.905 | 54,130,293 |
|
|
||||
|
|
||||
|
|